S-3 S-3ASR EX-FILING FEES 0000885725 BOSTON SCIENTIFIC CORP 0000885725 2025-02-18 2025-02-18 0000885725 1 2025-02-18 2025-02-18 0000885725 2 2025-02-18 2025-02-18 0000885725 3 2025-02-18 2025-02-18 iso4217:USD xbrli:pure xbrli:shares
Calculation of Filing Fee Tables |
S-3 |
BOSTON SCIENTIFIC CORP |
Table 1: Newly Registered and Carry Forward Securities |
---|
| | Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward |
---|
Newly Registered Securities |
Fees to be Paid | 1 | Debt | Senior Debt Securities | 457(r) | | | | 0.0001531 | | | | | |
Fees to be Paid | 2 | Debt | Subordinated Debt Securities | 457(r) | | | | 0.0001531 | | | | | |
Fees to be Paid | 3 | Other | Guarantees | 457(r) | | | | 0.0001531 | | | | | |
Fees Previously Paid | | | | | | | | | | | | | |
Carry Forward Securities |
Carry Forward Securities | | | | | | | | | | | | | |
| | | Total Offering Amounts: | | $ 0.00 | | $ 0.00 | | | | |
| | | Total Fees Previously Paid: | | | | $ 0.00 | | | | |
| | | Total Fee Offsets: | | | | $ 0.00 | | | | |
| | | Net Fee Due: | | | | $ 0.00 | | | | |
1 | (1) The debt securities may be issued by Boston Scientific Corporation or American Medical Systems Europe B.V. Debt securities issued by Boston Scientific Corporation may be guaranteed by American Medical Systems Europe B.V. Debt securities issued by American Medical Systems Europe B.V. may be guaranteed by Boston Scientific Corporation. No separate consideration will be received for any guarantee of debt securities. Accordingly, pursuant to Rule 457(n) of the Securities Act of 1933, as amended, no separate filing fee is required. (2) The registrants are relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all of the registration fee. In connection with the securities offered hereby, the registrants will pay "pay-as-you-go registration fees" in accordance with Rule 456(b). The registrants will calculate the registration fee applicable to an offer of securities pursuant to this registration statement based on the fee payment rate in effect on the date of such fee payment. (3) An unspecified aggregate initial offering price and number of securities of each identified class is being registered and may from time to time be offered at unspecified prices. |
|
|
2 | (1) The debt securities may be issued by Boston Scientific Corporation or American Medical Systems Europe B.V. Debt securities issued by Boston Scientific Corporation may be guaranteed by American Medical Systems Europe B.V. Debt securities issued by American Medical Systems Europe B.V. may be guaranteed by Boston Scientific Corporation. No separate consideration will be received for any guarantee of debt securities. Accordingly, pursuant to Rule 457(n) of the Securities Act of 1933, as amended, no separate filing fee is required. (2) The registrants are relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all of the registration fee. In connection with the securities offered hereby, the registrants will pay "pay-as-you-go registration fees" in accordance with Rule 456(b). The registrants will calculate the registration fee applicable to an offer of securities pursuant to this registration statement based on the fee payment rate in effect on the date of such fee payment. (3) An unspecified aggregate initial offering price and number of securities of each identified class is being registered and may from time to time be offered at unspecified prices. |
|
|
3 | (1) The debt securities may be issued by Boston Scientific Corporation or American Medical Systems Europe B.V. Debt securities issued by Boston Scientific Corporation may be guaranteed by American Medical Systems Europe B.V. Debt securities issued by American Medical Systems Europe B.V. may be guaranteed by Boston Scientific Corporation. No separate consideration will be received for any guarantee of debt securities. Accordingly, pursuant to Rule 457(n) of the Securities Act of 1933, as amended, no separate filing fee is required. (2) The registrants are relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all of the registration fee. In connection with the securities offered hereby, the registrants will pay "pay-as-you-go registration fees" in accordance with Rule 456(b). The registrants will calculate the registration fee applicable to an offer of securities pursuant to this registration statement based on the fee payment rate in effect on the date of such fee payment. (3) An unspecified aggregate initial offering price and number of securities of each identified class is being registered and may from time to time be offered at unspecified prices. |
|
|